|
| Mutation specific antibodies: tool or dinosaur |
|
https://doi.org/10.18632/oncotarget.633
Andreas von Deimling, Felix Sahm, and David Capper
|
| 907-908 |
|
| Targeting Rho Associated Kinases in Leukemia and Myeloproliferative Neoplasms |
|
https://doi.org/10.18632/oncotarget.664
Raghuveer Singh Mali, and Reuben Kapur
|
| 909-910 |
|
| Novel Antagonists of Heparin Binding Growth Factors |
|
https://doi.org/10.18632/oncotarget.645
Fabiola Cecchi, and Donald P Bottaro
|
| 911-912 |
|
| Bruton’s tyrosine kinase: oncotarget in myeloma |
|
https://doi.org/10.18632/oncotarget.655
Yu-Tzu Tai, and Kenneth C. Anderson
|
| 913-914 |
|
| Second Primary Malignancies and Myeloma Therapy: Fad or Fact |
|
https://doi.org/10.18632/oncotarget.661
Saad Z Usmani
|
| 915-916 |
|
| Notching up a new therapeutic strategy for NonSmall Cell Lung Carcinoma NSCLC |
|
https://doi.org/10.18632/oncotarget.671
Antonio Maraver, and Manuel Serrano
|
| 917-918 |
|
| Endothelial chemokine receptors as facilitators of tumor cell extravasation |
|
https://doi.org/10.18632/oncotarget.672
Alexandra Hoos, Monika J. Wolf, Judith Bauer, Lubor Borsig, and Mathias Heikenwalder
|
| 919-920 |
|
| Neuropilins are multifunctional coreceptors involved in tumor initiation growth metastasis and immunity |
|
https://doi.org/10.18632/oncotarget.626
Gerald J Prud'homme, and Yelena Glinka
|
| 921-939 |
|
| Glyceraldehyde3Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma |
|
https://doi.org/10.18632/oncotarget.623
Shanmugasundaram Ganapathy-Kanniappan, Rani Kunjithapatham, and Jean-Francois Geschwind
|
| 940-953 |
|
| Mutations and Deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR Cascades |
|
https://doi.org/10.18632/oncotarget.652
James Andrew McCubrey, Linda Steeman, William Chappell, Stephen Abrams, Giuseppe Montalto, Melchiorre Cervello, Ferdinando Nicoletti, Paolo Fagone, Grazia Malaponte, Maria Mazzarino, Saverio Candido, Massimo Libra, Jorg Basecke, Sanja Mijatovic, Danijela Maksimovic-Ivanic, Michele Milella, Agostino Tafuri, Lucio Cocco, Camilla Evangelisti, Francesca Chiarini, and Alberto Martelli
|
| 954-987 |
|
| Antagonists of growth hormonereleasing hormone suppress in vivo tumor growth and gene expression in triple negative breast cancers |
|
https://doi.org/10.18632/oncotarget.634
Roberto Perez, Andrew V Schally, Irving Vidaurre, Ricardo Rincon, Norman L Block, and Ferenc G Rick
|
| 988-997 |
|
| Phenotypic Screening Reveals Topoisomerase I as a Breast Cancer Stem Cell Therapeutic Target |
|
https://doi.org/10.18632/oncotarget.632
Fang Zhang, Kristi Rothermund, Sajithal B. Gangadharan, Yves Pommier, Edward V. Prochownik, and John S. Lazo
|
| 998-1010 |
|
| Genetic and epigenetic loss of microRNA31 leads to feedforward expression of EZH2 in melanoma |
|
https://doi.org/10.18632/oncotarget.622
Irfan A Asangani, Paul W Harms, Lois Dodson, Mithil Pandhi, Lakshmi P Kunju, Christopher A Maher, Douglas R Fullen, Timothy M Johnson, Thomas J Giordano, Nallasivam Palanisamy, and Arul M Chinnaiyan
|
| 1011-1025 |
|
| DNA damageinduced activation of ATM promotes βTRCPmediated Mdm2 ubiquitination and destruction |
|
https://doi.org/10.18632/oncotarget.640
Zhiwei Wang, Hiroyuki Inuzuka, Jiateng Zhong, Hidefumi Fukushima, Lixin Wan, Pengda Liu, and Wenyi Wei
|
| 1026-1035 |
|
| Modulating Antiangiogenic Resistance by Inhibiting the Signal Transducer and Activator of Transcription 3 Pathway in Glioblastoma |
|
https://doi.org/10.18632/oncotarget.663
John de Groot, Ji Liang, Ling-Yuan Kong, Jun Wei, Yuji Piao, Gregory Fuller, Wei Qiao, and Amy B Heimberger
|
| 1036-1048 |
